Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study-论文-万方医学网

首页> > Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

导出原文传递

翻译打印收藏纠错

第一作者： Deesje,Doppenberg

作者： Deesje,Doppenberg ; Thomas F.,Stoop ; Susan,van Dieren ; Matthew H. G.,Katz ; Quisette P.,Janssen ; Naaz,Nasar ; Laura R.,Prakash ; Rutger T.,Theijse ; Ching-Wei D.,Tzeng ; Alice C.,Wei ; Amer H.,Zureikat ; Bas,Groot Koerkamp ; Marc G.,Besselink

关键词 Localized pancreatic adenocarcinoma Preoperative FOLFIRINOX Serum CEA Non-elevated CA-19.9 Overall survival

发布时间 2024-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

相似文献

同项目论文

相关期刊

检索历史 清除

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study

相似文献

同项目论文

相关期刊

检索历史清除